시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 근적외선 이미징 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종사용자별, 지역별 전망 및 예측(2023-2030년)
Global Near Infrared Imaging Market Size, Share & Trends Analysis Report By Product (Reagents (Indocyanine Green (ICG) and Others), Devices), By Application, By End User, By Regional Outlook and Forecast, 2023 - 2030
상품코드 : 1429150
리서치사 : KBV Research
발행일 : 2024년 01월
페이지 정보 : 영문 362 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 5,206,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 6,248,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 8,747,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

근적외선 이미징 시장 규모는 2030년까지 32억 달러에 달하고, 예측 기간 동안 연평균 6.0% 시장 성장률을 보일 것으로 예상됩니다.

KBV Cardinal Matrix의 분석에 따르면, 라이카 마이크로시스템즈(Danaher Corporation)는 근적외선 이미징 시장의 주요 선구자이며, 2020년 4월에는 새로운 주력 공초점 현미경 플랫폼인 STELLARIS를 발표했습니다. 플랫폼인 스텔라리스(STELLARIS)를 출시하여 살아있는 세포와 조직의 3차원 이미지를 촬영할 수 있는 능력을 강화했습니다. 이 플랫폼은 공초점 이미징에 정보 차원을 추가하여 모든 실험에서 수명 기반 정보에 대한 액세스를 제공함으로써 Medtronic PLC, Stryker Corporation, Olympus Corporation과 같은 기업들은 근적외선 이미징 시장의 주요 혁신 기업입니다. 근적외선 이미징 시장의 주요 혁신 기업입니다.

COVID-19의 영향 분석

팬데믹은 전 세계 공급망에 혼란을 일으켜 NIR 이미징 장비 및 부품의 생산과 유통에 영향을 미쳤습니다. 이러한 혼란은 제품 공급 지연과 제조업체의 비용 증가로 이어졌습니다. 많은 연구 기관과 기업이 코로나19 관련 연구에 자원을 투입하면서 NIR 이미징 기술 개발과 같은 비본질적인 분야에 대한 투자가 감소했습니다. 이러한 초점 전환은 시장에서의 기술 혁신과 제품 개발을 지연시켰습니다. 따라서 코로나19 사태는 NIR 이미징 시장에 도전을 가져왔지만, 특히 이미징 기술에 대한 수요가 증가하고 있는 헬스케어 분야에서는 기회를 창출하기도 했습니다.

시장 성장 요인

수술 건수가 증가함에 따라 수술 중 외과의사가 더 높은 정확도를 달성할 수 있도록 실시간으로 고해상도 이미지를 제공할 수 있는 영상 처리 시스템에 대한 수요가 증가하고 있습니다. 또한, 시각화를 위해 고도의 영상 기술이 필요한 최소침습 수술에 대한 선호도가 높아지면서 NIR 영상 시스템에 대한 수요도 증가하고 있습니다. 심혈관 질환, 암, 신경혈관 질환, 소화기 질환 등 많은 질병의 발생 빈도와 발병률이 증가하고 있으며, 이는 수술 건수 증가에 기여하고 있습니다. 또한, 일부 개발도상국은 저렴한 비용과 양질의 의료 서비스로 인해 의료 관광의 인기 목적지가 되고 있으며, NIR 시스템과 같은 첨단 영상 처리 기술에 대한 수요는 진단 및 치료 서비스를 찾는 의료 관광객 증가에 대응해야 할 필요성에 기인하고 있습니다. 수요를 창출하고 있습니다. 이처럼 NIR 이미징과 같은 다양한 이미징 양식에 대한 수요는 생명과학 연구 사업의 확장과 직결되는 결과로 최근 몇 년동안 확대되고 있으며, 이는 시장 확대를 촉진하고 있습니다.

시장 성장 억제요인

NIR 이미징 시스템을 포함한 의료기기에 대한 엄격한 규제 요건은 제조업체, 유통업체 및 의료 서비스 제공업체에 어려움을 초래할 수 있습니다. 긴 승인 절차, 복잡한 규정 준수 기준, 높은 수준의 문서화 요건 등이 이러한 장애물로 인해 신제품 출시가 늦어질 수 있습니다. 그 결과, 제조업체들은 NIR 이미징 시스템의 비용과 시장 출시 기간 증가에 직면할 수 있으며, 이는 혁신을 저해하고 의료진과 환자들의 첨단 기술 활용을 제한할 수 있습니다. 또한, 규제 장벽은 NIR 이미징 기술의 국제 경쟁력에도 영향을 미칠 수 있습니다. 신흥 시장과 같이 규제가 느슨한 지역에서는 경쟁 이미징 기술이 더 쉽게 자리를 잡을 수 있으며, 지역별로 첨단 의료 이미징 기술에 대한 접근성 격차가 발생할 수 있습니다. 이러한 모든 문제들은 국제적으로 시장 입지를 확대하려는 제조업체들에게 장애물이 될 수 있으며, 전체 시장의 성장 잠재력을 제한할 수 있습니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장 요람

제3장 시장 개요

제4장 경쟁 분석 - 세계

제5장 세계의 근적외선 이미징 시장 : 제품별

제6장 세계의 근적외선 이미징 시장 : 용도별

제7장 세계의 근적외선 이미징 시장 : 최종사용자별

제8장 세계의 근적외선 이미징 시장 : 지역별

제9장 기업 개요

제10장 근적외선 이미징 시장을 위한 성공 필수 조건

LSH
영문 목차

영문목차

The Global Near Infrared Imaging Market size is expected to reach $3.2 billion by 2030, rising at a market growth of 6.0% CAGR during the forecast period.

NIR imaging reagents are used in various industrial applications, such as quality control in manufacturing processes, food safety testing, and material characterization. Therefore, the reagents segment captured $1,204.2 million revenue in the market in 2022. Moreover, the increasing use of NIR imaging in medical diagnostics and research has driven the demand for NIR imaging reagents. These reagents play a crucial role in enhancing the sensitivity and specificity of NIR imaging techniques, particularly in applications such as fluorescence imaging and molecular imaging.

The major strategies followed by the market participants are Product launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In August, 2022, Shimadzu introduced the LuminousQuester NI near-infrared imaging system, which comprises dedicated software and a camera that is capable of concurrently imaging visible light and near-infrared light. The system records near-infrared light that is less interfered with indoor lighting and because of this imaging can be carried out in a vast range of testing environments. Additionally, In November, 2023, Olympus Corporation had announced the release of its next-generation EVIS X1™ endoscopy system in China, completing its availability in all major markets. The EVIS X1 is Olympus' most advanced endoscopy system. Olympus® GI endoscopy systems, including the EVIS X1, assisted physicians in diagnosing.

Based on the Analysis presented in the KBV Cardinal matrix; Leica Microsystems GmbH (Danaher Corporation) is the major forerunner in the Near Infrared Imaging Market. In April, 2020, Leica Microsystems introduced STELLARIS, a flagship new confocal microscopy platform. STELLARIS enhanced the capability of capturing three-dimensional images of living cells and tissues. The platform added a dimension of information to confocal imaging and provided access to lifetime-based information in every experiment. Companies such as Medtronic PLC, Stryker Corporation and Olympus Corporation are some of the key innovators in the Near Infrared Imaging Market.

COVID-19 Impact Analysis

The pandemic led to disruptions in global supply chains, affecting the production and distribution of NIR imaging devices and components. This disruption resulted in delays in product availability and increased costs for manufacturers. Many research institutions and companies redirected their resources toward COVID-19-related research, leading to reduced investment in non-essential areas such as NIR imaging technology development. This shift in focus slowed down innovation and product development in the market. Therefore, while the COVID-19 pandemic presented challenges for the NIR imaging market, it also created opportunities, especially in the healthcare sector where there was increased demand for imaging technologies.

Market Growth Factors

As the number of surgeries increases, there is a greater demand for imaging systems that can provide real-time, high-resolution imaging to aid surgeons in achieving greater precision during procedures. Moreover, the growing preference for minimally invasive surgical techniques, which require advanced imaging technologies for visualization, has led to an increased demand for NIR imaging systems. The frequency and incidence of a number of diseases, including cardiovascular diseases, cancer, neurovascular disorders, and gastrointestinal diseases, are on the rise, which is contributing to an increase in the number of surgical procedures performed. Additionally, some developing countries are becoming popular destinations for medical tourism due to lower costs and high-quality healthcare services. The demand for advanced imaging technologies like NIR systems is driven by the need to cater to the growing number of medical tourists seeking diagnostic and treatment services. Thus, the need for diverse imaging modalities, such as NIR imaging, has expanded in recent years as a direct result of the expansion of the life sciences research business, which will bolster the expansion of the market.

Market Restraining Factors

Stringent regulatory requirements for medical devices, including NIR imaging systems, can pose challenges for manufacturers, distributors, and healthcare providers. These hurdles may include lengthy approval processes, complex compliance standards, and high documentation requirements, all of which can delay the introduction of new products to the market. As a result, manufacturers may face increased costs and time-to-market for their NIR imaging systems, which can hinder innovation and limit the availability of advanced technologies for healthcare providers and patients. Furthermore, regulatory hurdles can impact the global competitiveness of NIR imaging technology. In regions with more relaxed regulatory environments, such as emerging markets, competing imaging technologies may gain a foothold more easily, potentially leading to disparities in access to advanced medical imaging technologies based on geographical location. Thus, all these challenges can create hurdles for manufacturers seeking to expand their market presence internationally and may limit the overall growth potential of the market.

By Product Analysis

Based on the product, the market is bifurcated into devices and reagents. The reagents segment dominated the revenue share in the near infrared imaging market in 2022. NIR imaging reagents are used in various industrial applications, such as quality control in manufacturing processes, food safety testing, and material characterization. Moreover, the increasing use of NIR imaging in medical diagnostics and research has driven the demand for NIR imaging reagents. These reagents play a crucial role in enhancing the sensitivity and specificity of NIR imaging techniques, particularly in applications such as fluorescence imaging and molecular imaging.

By Reagents Analysis

Based on the reagents type, the reagents segment is further fragmented into indocyanine green (ICG) and other reagents. The indocyanine green (ICG) segment witnessed the highest revenue share in the market in 2022. ICG is used in NIR imaging for vascular imaging and perfusion studies. It can be injected intravenously to assess blood flow dynamics, tissue perfusion, and vascular integrity in various medical specialties, including cardiology, neurology, and vascular surgery. In oncology, ICG is utilized for NIR imaging in cancer diagnosis and treatment. It can be conjugated with targeting moieties to specifically bind to cancer cells, allowing for the visualization of tumors and metastases. This application has driven the demand for ICG reagents in NIR imaging for cancer-related research and clinical use.

By Devices Analysis

On the basis of device type, the device segment of the market is segmented into near-infrared fluorescence imaging systems and near-infrared fluorescence & bioluminescence imaging systems. The near infrared fluorescence imaging systems segment recorded the largest revenue share in the market in 2022. The demand for NIR fluorescence imaging systems is driven by their ability to provide high-resolution, real-time imaging of tissues and structures, making them valuable tools in medical imaging, research, and clinical practice. The increase in the prevalence of gastrointestinal, cardiovascular, and cancer diseases are the main fields where these devices are widely employed. Additionally, the NIR fluorescence imaging systems help in the expedited discovery of functions associated with lymphatic systems. This is possible because of NIR's high sensitivity, which allows high temporal and spatial resolutions.

By Application Analysis

On the basis of application, the market is divided into preclinical imaging, cancer surgeries, gastrointestinal surgeries, cardiovascular surgeries, plastic/reconstructive surgeries, and other applications. The cardiovascular surgeries segment recorded a promising growth rate in the market in 2022. Cardiovascular diseases, including coronary artery disease, heart failure, and valvular heart disease, are among the leading causes of death worldwide. The high prevalence of these conditions drives the demand for cardiovascular surgeries as a treatment option to manage and treat these diseases. The aging population worldwide has led to an increase in the prevalence of age-related cardiovascular conditions, such as atherosclerosis and heart valve degeneration. As the population ages, there is a growing demand for cardiovascular surgeries to address these age-related conditions.

By End Use Analysis

Based on end-user, the market is categorized into hospitals & clinics, pharmaceutical & biotechnology companies, and research laboratories. The hospitals and clinics segment witnessed the highest revenue share in the market in 2022. The demand for NIR imaging systems in hospitals and clinics is driven by their versatility, non-invasive nature, and ability to provide real-time insights into biological processes. Near-infrared sensors built into laparoscopic instruments assist surgeons to prevent unintentional blood vessel rupture. The use of these technologies aids in reducing surgical errors, shortening hospital stays, and lowering patient healthcare expenses.

By Regional Analysis

On the basis of region, the near infrared imaging market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the largest revenue share in the market in 2022. North America has a significant healthcare expenditure, with a focus on advanced medical technologies and innovative treatments. The increasing investment in healthcare infrastructure and research and development activities drives the demand for advanced imaging systems like NIR for diagnostic and therapeutic applications. Additionally, a rise in reconstructive and cosmetic procedures in the nation as a result of higher spending and growing awareness of early diagnosis is anticipated to generate significant growth potential.

Recent Strategies Deployed in the Market

List of Key Companies Profiled

Global Near Infrared Imaging Market Report Segmentation

By Product

By Application

By End User

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Competition Analysis - Global

Chapter 5. Global Near Infrared Imaging Market by Product

Chapter 6. Global Near Infrared Imaging Market by Application

Chapter 7. Global Near Infrared Imaging Market by End User

Chapter 8. Global Near Infrared Imaging Market by Region

Chapter 9. Company Profiles

Chapter 10. Winning imperatives of Near Infrared Imaging Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기